STAT China: Lineup for Hong Kong IPO grows, and a conversation with Junshi’s Li Ning

, , Comments Off on STAT China: Lineup for Hong Kong IPO grows, and a conversation with Junshi’s Li Ning

In this edition, we feature a conversation with Li Ning, CEO of Junshi Biosciences, along with other news and notes from Chinese biotech.
( read original story …)